Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

ClinicalTrials.gov ID: NCT01020396

Public ClinicalTrials.gov record NCT01020396. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Parallel Group Study Comparing the Bioequivalence of Teva Pharmaceuticals, USA's Generic Formulation of Metronidazole Vaginal Gel, 0.75% and MetroGel-Vaginal® Metronidazole Vaginal Gel, 0.75% in the Treatment of Bacterial Vaginosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to demonstrate comparable efficacy, safety, and tolerability of Teva Pharmaceuticals USA's generic formulation of Metronidazole Vaginal Gel, 0.75% and 3M Pharmaceuticals' MetroGel-Vaginal® metronidazole vaginal gel, 0.75% to establish clinical equivalence in the treatment of bacterial vaginosis.

Study identification

NCT ID
NCT01020396
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Teva Pharmaceuticals USA
Industry
Enrollment
579 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2001
Primary completion
Feb 28, 2003
Completion
Feb 28, 2003
Last update posted
Aug 18, 2024

2002 – 2003

United States locations

U.S. sites
37
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Clinic for Women, PA Huntsville Alabama 35801
Medical Affiliated Research Center, Inc. Huntsville Alabama 35801
Edinger Medical Group Fountain Valley California 92708
Office of Drs. Shepard and Lugerner, PC Washington D.C. District of Columbia 20006
Meadowcrest Women's Center Crystal River Florida 34429
Florida Medical and Research Institute, PA Gainesville Florida 32607
The Florida Wellcare Alliance, LC Inverness Florida 34452
Wellness Center for Gyn & Osteoporosis Inverness Florida 34452
Florida Medical and Research Institute, PA Ocala Florida 34471
KGR, LLC Riverdale Georgia 30274
Women's Health Practice Champaign Illinois 61820
Central Kentucky Research Associates, Inc. Lexington Kentucky 40509
New Orleans Institute of Clinical Investigation New Orleans Louisiana 70112
Phoenix Ob-Gyn Associated Moorestown New Jersey 08057
Phoenix Ob-Gyn Associates Mount Holly New Jersey 08060
Kings County Hospital Center Brooklyn New York 11203
SUNY Downstate Medical Center Brooklyn New York 11203
Chapel Hill Obstetrics and Gynecology, PA Chapel Hill North Carolina 27514
Cooperfield Obstetrics and Gynecology, LLC Concord North Carolina 28025
O.U. Physicians' Building Oklahoma City Oklahoma 73104
The OU Medical Center Oklahoma City Oklahoma 73104
University of Oklahoma Health Services Center Oklahoma City Oklahoma 73104
Medford Women's Clinic Medford Oregon 97504
Philadelphia Women's Research Philadelphia Pennsylvania 19114
Elite Medical Research, Inc. Sellersville Pennsylvania 18960
Stonebridge OB/GYN Associates Sellersville Pennsylvania 18960
Anderson Family Care Anderson South Carolina 29621
Carolina OB/GYN Anderson South Carolina 29621
Primary Care Associates Anderson South Carolina 29621
Radiant Research Anderson South Carolina 29621
Research Memphis Memphis Tennessee 38116
Millennium Clinical Research Center, LLC Arlington Virginia 22203
Women's Health Associates, PC Fairfax Virginia 22031
Office of H. Sharon Sethi Fairfax Virginia 22033
MedSource, Inc. Richmond Virginia 23229
Office of Max S. Maizels, MD Richmond Virginia 23229
Office of Prescott W. Prillaman, MD, PC Richmond Virginia 23229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01020396, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2024 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01020396 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →